Study points to need for Group B Strep vigilance in newborns

03/21/2013 | Minnesota Public Radio

Health experts in Minnesota are expressing concern regarding an increase in cases of a drug-resistant form of Group B Streptococcus called serotype IV. The strain made up 16% of neonatal cases in 2010, according to a study published in the CDC journal Emerging Infectious Diseases. Researcher Dr. Patricia Ferrieri highlighted the importance of watching for signs of drug-resistant Group B Strep in an infant's first days of life.

View Full Article in:

Minnesota Public Radio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC